Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
29.00
+0.50
+(1.75%)
At close: 5:29:35 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
37,116
37,116
67,752
-928
45,918.90
Investing Cash Flow
14,422
14,422
-12,808
-3,825
-4,491.23
Financing Cash Flow
-5,357
-5,357
-4,513
-3,732
-4,230.48
End Cash Position
169,442
169,442
123,261
72,830
81,314.99
Capital Expenditure
--
--
-12,808
-3,825
-4,491.23
Free Cash Flow
37,116
37,116
54,944
-4,753
41,427.67
12/31/2021 - 6/2/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LYTIX.OL Lytix Biopharma AS
5.08
-1.93%
AZT.OL ArcticZymes Technologies ASA
18.22
-2.04%
IVACC.ST Intervacc AB (publ)
1.0000
+4.17%
CANTA.ST Cantargia AB (publ)
1.6970
-0.88%
HNSA.ST Hansa Biopharma AB (publ)
25.14
+7.07%
BSEM BioStem Technologies, Inc.
13.04
+0.31%
ABCL AbCellera Biologics Inc.
2.9500
+4.61%
VRTX Vertex Pharmaceuticals Incorporated
482.74
+0.50%
MRNA Moderna, Inc.
33.47
+0.56%